Catalyst Pharmaceutical Inc. (CPRX) — Analysis Summary
Catalyst Pharmaceutical Inc. (CPRX) has a market cap of $3.44B with year-over-year revenue growth of +23.5%. Net margin stands at 33.3%. The stock trades at a P/E ratio of 21.0.
Key Takeaways
- Revenue changed +23.5% year-over-year
- Net margin of 33.3%
- P/E ratio of 21.0
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, CPRX posted revenue growth of +23.5% and trades at a P/E of 21.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.